Funding for this research was provided by:
Received: 7 June 2021
Accepted: 27 March 2022
First Online: 13 April 2022
: This study was approved by Human Subjects Committees of the University of Georgia and the University of Washington (STUDY00009003), and all participating clinicians provided written or electronic informed consent.
: Not applicable.
: Dr. Lutz is co-founder of Anavasi Diagnostics, Inc. that is developing point-of-care diagnostics. Dr Thompson has provided medical advice to Roche Molecular Diagnostics and Visby Medical, who produce point of care tests for respiratory infections.